Haemonetics Corporation

AI Score

XX

Unlock

62.91
-0.64 (-1.01%)
At close: Apr 01, 2025, 3:59 PM
63.94
1.64%
After-hours: Apr 01, 2025, 08:00 PM EDT

Haemonetics Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income 117.56M115.4M43.38M79.47M76.53M
Depreciation & Amortization 97.22M93.31M97.75M84.29M110.29M
Stock-Based Compensation 28.33M25.58M24.36M25.52M20.45M
Other Working Capital -35.03M-20.65M-12.15M-8.47M-1.4M
Other Non-Cash Items 24.39M8.48M16.95M-919K42.47M
Deferred Income Tax -11.04M4.78M5.01M-19.87M-6.96M
Change in Working Capital -74.7M25.5M-15.18M-59.68M-84.56M
Operating Cash Flow 181.75M273.06M172.26M108.81M158.22M
Capital Expenditures -66.3M-110.19M-96.51M-37.04M-48.76M
Acquisitions -242.35M-2M8.14M-390.22M-25.19M
Purchase of Investments n/a-33.2Mn/an/an/a
Sales Maturities Of Investments n/an/an/an/an/a
Other Investing Acitivies -13.74M1.61M2.02M1.81M16.77M
Investing Cash Flow -322.39M-143.79M-86.34M-425.44M-57.18M
Debt Repayment 37.75M-9.63M-17.5M418.13M31.88M
Common Stock Repurchased n/a-75Mn/an/a-175M
Dividend Paid n/an/an/an/an/a
Other Financial Acitivies -6.81M-15.74M-4.8M-50.67M11.92M
Financial Cash Flow 38.16M-100.36M-15.75M367.45M-131.21M
Net Cash Flow -105.67M24.97M67.19M54.99M-32.04M
Free Cash Flow 115.45M162.87M75.75M71.77M109.46M